link) for CY21 as (1) sales growth of 5-8%, (2) EPS growth of 5-11%" /> link) for CY21 as (1) sales growth of 5-8%, (2) EPS growth of 5-11%" />
Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  

| More

3M India - CY21 guidance of parent: Focus on healthy revenue growth and FCF, but limited capex - ICICI Securities

Posted On: 2021-01-27 22:44:28 (Time Zone: Arizona, USA)

3M USA (3M India's parent) announced its guidance (link) for CY21 as (1) sales growth of 5-8%, (2) EPS growth of 5-11% indicating margin expansion and (3) FCF conversion of 95-105%. It also plans to invest in markets with strong and sustainable demand in segments such as personal safety, healthcare, auto OEM, semiconductor, data center and home improvement. Likely implications for 3M India: (1) As 3M India offers healthy growth in most of the above mentioned areas, we believe 3M USA may invest in R&D, technology and new products in India, (2) 3M India is likely to report strong revenue growth in CY20 with margin expansion considering favourable base of CY20 which was impacted by covid and (3) considering PLI schemes, consensus expectation was higher capex by 3M India. However, as the parent has high focus on FCF conversion, it may result in lower-than-expected capex by 3M India. We remain positive on 3M India due to competitive advantages like (1) strong brands, (2) established distribution network and (3) access to technology pool of the parent. Maintain ADD with a DCF-based TP of Rs21,800 (59x FY23E).

- CY21 guidance announcement by 3M USA: 3M USA has announced CY21 guidance as (1) sales growth of 5-8%, (2) EPS of US$9.2-US$9.7. It indicates EPS growth of 5-11% indicating margin expansion, (3) capex of US$1.8bn-US$2bn and (4) FCF conversion of 95-105%.

- Likely implications for 3M India: The company is also expected to focus on EBITDA margin expansion in CY21. As CY20 was impacted by covid, we believe it will be able to report EBITDA margin expansion in CY21. Considering high focus on FCF conversion by the parent, we believe there may not be any major capex in India, too.

- Requirement of capex to tap PLI opportunity: We believe 3M India needs to invest in local manufacturing units to cater to likely increase in domestic manufacturing activity post PLI announcements. Early capex by 3M India will allow it to gain market share as well as improve margins.

- Focus on investments in end markets with strong demand: 3M USA plans to invest in markets where demand is strong and sustainable. It plans to invest in personal safety, healthcare, auto OEM, semiconductor, data center and home improvement segments. We believe as India offers strong and sustainable growth (CY1995-2020 revenue CAGR: 18.7%) in most of these segments, 3M USA may invest more in new products, services, R&D and technology in India.

- Maintain ADD: We model 3M India to report revenue and PAT CAGRs of 15.7% and 40.1%, respectively, over FY21-FY23E. RoE is also expected to remain above the cost of capital over the same timeframe. We maintain our ADD rating on the stock with DCF-based target price of Rs21,800 (59x FY23E). Key risks: Failure of new products and prolonged slowdown in the economy.

Shares of 3M INDIA LTD. was last trading in BSE at Rs.19814.05 as compared to the previous close of Rs. 20033.65. The total number of shares traded during the day was 215 in over 129 trades.

The stock hit an intraday high of Rs. 20050 and intraday low of 19809. The net turnover during the day was Rs. 4276398.

Source: Equity Bulls

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

4th Industrial Conclave - Bullish undertone, favourable valuation - HDFC Securities

Sanofi India - Weak quarter; sequential improvement - ICICI Securities

Sunteck Realty - All eyes on upcoming launches - ICICI Securities

Company Update - Tata Motors - ICICI Direct

Q4CY20 Company Update - Mahindra CIE Automotive - ICICI Direct

Event Update - Hindalco - ICICI Direct

EY report launch at BioAsia 2021 - Moving the needle: Healthcare industry in a post-COVID world

Initiating Coverage - Dalmia Bharat Ltd - HDFC Securities Retail Research Desk

Initiating Coverage - Mastek Ltd - HDFC Securities Retail Research Desk

Hindalco Industries - Status quo maintained - ICICI Securities

Tata Motors - India business scaling in the right direction - ICICI Securities

IPO Review - Heranba Industries Ltd

Company Update - Narayana Hrudayalaya - ICICI Direct

Ambuja Cements - Market share sustenance key for rerating - ICICI Securities

ADD on Astral Poly Technik - An 'astr'onomical growth story - HDFC Securities

FMCG Sector Update Report - Divergence narrows; refocus on core - HDFC Securities

Maintain REDUCE on Jubilant FoodWorks - More legs for growth; reflecting confidence on core - HDFC Securities

Torrent Power - Growth acceleration - ICICI Securities

Mahindra CIE Automotive - CY20 performance closes on a strong note - ICICI Securities

Q3FY21 Company Update - V-Guard Industries - ICICI Direct

Quant Pick - Indus Towers - ICICI Direct

Q4CY20 Result Update - Ambuja Cement - ICICI Direct

Q3FY21 Company Update - Nesco Ltd - ICICI Direct

Maintain BUY on Ambuja Cements - Healthy quarter; multiple triggers ahead - HDFC Securities

Heranba Industries Ltd. - IPO - Sound Financials & Promising Outlook Augur Well

India Equity Strategy Report - Quarterly flipbook: Q3 - upgrades galore! - HDFC Securities

Earnings Wrap Q3FY21: Encouraging quarter, broad based recovery under way!

Shilpa Medicare - USFDA import alert at Jadcherla unit - ICICI Securities

Q3FY21 Company Update - Indian Bank - ICICI Direct

Quant Pick - Torrent Power - ICICI Direct

GE T&D India - Strong cashflow - ICICI Securities

Q3FY21 Result Update - Graphite India - ICICI Direct

Q4CY2020 Result Update - Varun Beverages - ICICI Direct

Q3FY21 Company Update - NBCC Ltd - ICICI Direct

Quant Pick - United Breweries - ICICI Direct

Q4CY2020 Result Update - Nestlé India - ICICI Direct

Q3FY21 Result Update - Time Technoplast - ICICI Direct

Healthy Business Performance Puts ITC Stock Recovery on Track

Gold - Feb 17, 2021 - Reliance Securities

Maintain REDUCE on Nestle India - Steady revenue show; employee cost dents margins - HDFC Securities

Varun Beverages - Q4 CY20 Result and Concall Update - YES Securities

Nestle India - Q4 CY20 Result Update - YES Securities

Reiterate BUY on JMC Projects - Some hits, some misses - HDFC Securities

Varun Beverages - Strong volumes; higher margins - ICICI Securities

Computer Age Management Services - Play on industry AUM growth - ICICI Securities

Nestle India - Just a tad underwhelming (given the high benchmarks expected from Nestle India) - ICICI Securities

NHPC - Earnings robust; projects on track - ICICI Securities

Maintain BUY on ITD Cementation - Gradual recovery shaping up - HDFC Securities

Techno Electric & Engineering - Strong margins, healthy growth outlook - ICICI Securities

Time Technoplast - Outlook upbeat; execution remains key - ICICI Securities

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020